By Michael Nevradakis, Ph.D.
“Two lawsuits working their way through the U.K. court system could determine the fate of a class-action suit filed against AstraZeneca by more than 80 people who allege they or a family member were injured by the drugmaker’s COVID-19 vaccine.
The two lawsuits are being heard as test cases for the larger class-action lawsuit.
One of the test cases was filed in the U.K.’s High Court by Jamie Scott, a father of two who sustained a permanent brain injury as a result of blood clots caused by the vaccine in April 2021.
The Telegraph, reporting Wednesday on the Scott case, noted that the Oxford-AstraZeneca COVID-19 vaccine was “branded ‘defective’” and that case “will suggest claims over its efficacy were ‘vastly overstated.’”
The second test case was filed by the widower of 35-year-old Alpa Tailor, who died after receiving the AstraZeneca vaccine.
These “are the first lawsuits brought in England and Wales over an adverse reaction to a COVID-19 vaccine, according to publicly-available court records,” Reuters reported.
According to The Telegraph, “The test cases could pave the way for as many as 80 damages claims worth an estimated £80 million [$98.3 million] over a new condition known as vaccine-induced Immune Thrombocytopenia and Thrombosis (VITT) that was identified by specialists in the wake of the AstraZeneca COVID-19 vaccine rollout.”…”
0 Comments